Ameriprise Financial Inc. cut its holdings in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 83.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 101,970 shares of the semiconductor company's stock after selling 505,848 shares during the period. Ameriprise Financial Inc. owned about 0.31% of Axcelis Technologies worth $7,125,000 at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. SG Americas Securities LLC boosted its position in Axcelis Technologies by 10.7% in the 4th quarter. SG Americas Securities LLC now owns 7,630 shares of the semiconductor company's stock valued at $533,000 after buying an additional 738 shares during the last quarter. Avior Wealth Management LLC raised its stake in shares of Axcelis Technologies by 1,153.8% in the 4th quarter. Avior Wealth Management LLC now owns 489 shares of the semiconductor company's stock valued at $34,000 after purchasing an additional 450 shares during the period. Blue Trust Inc. raised its stake in shares of Axcelis Technologies by 85.5% in the 4th quarter. Blue Trust Inc. now owns 627 shares of the semiconductor company's stock valued at $44,000 after purchasing an additional 289 shares during the period. KBC Group NV increased its position in shares of Axcelis Technologies by 46.8% in the fourth quarter. KBC Group NV now owns 1,371 shares of the semiconductor company's stock valued at $96,000 after acquiring an additional 437 shares during the last quarter. Finally, Pacer Advisors Inc. increased its position in shares of Axcelis Technologies by 78,037.4% in the fourth quarter. Pacer Advisors Inc. now owns 782,155 shares of the semiconductor company's stock valued at $54,649,000 after acquiring an additional 781,154 shares during the last quarter. 89.98% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on the company. Needham & Company LLC reissued a "hold" rating on shares of Axcelis Technologies in a research report on Wednesday, February 12th. William Blair downgraded Axcelis Technologies from an "outperform" rating to a "market perform" rating in a research report on Wednesday, February 12th. Finally, B. Riley reissued a "neutral" rating and set a $50.00 price target (down previously from $80.00) on shares of Axcelis Technologies in a research report on Monday, April 21st. Five research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $131.00.
View Our Latest Stock Report on ACLS
Insider Activity
In other news, Director John T. Kurtzweil sold 1,682 shares of the stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $61.93, for a total value of $104,166.26. Following the completion of the transaction, the director now directly owns 35,050 shares in the company, valued at approximately $2,170,646.50. This represents a 4.58% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.48% of the stock is owned by corporate insiders.
Axcelis Technologies Price Performance
Shares of ACLS stock traded up $2.24 during trading on Tuesday, hitting $60.56. The company had a trading volume of 134,430 shares, compared to its average volume of 648,665. The stock's 50-day moving average price is $52.14 and its 200 day moving average price is $62.88. The firm has a market capitalization of $1.95 billion, a P/E ratio of 9.85, a price-to-earnings-growth ratio of 4.52 and a beta of 1.52. The company has a debt-to-equity ratio of 0.04, a quick ratio of 4.05 and a current ratio of 5.41. Axcelis Technologies, Inc. has a one year low of $40.40 and a one year high of $158.61.
Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last released its earnings results on Tuesday, May 6th. The semiconductor company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.65. Axcelis Technologies had a return on equity of 21.02% and a net margin of 19.75%. The firm had revenue of $192.56 million during the quarter, compared to analysts' expectations of $184.86 million. During the same period in the prior year, the company earned $1.57 earnings per share. The company's quarterly revenue was down 23.7% on a year-over-year basis. Equities analysts expect that Axcelis Technologies, Inc. will post 2.55 EPS for the current fiscal year.
Axcelis Technologies announced that its board has authorized a share buyback plan on Wednesday, March 12th that authorizes the company to repurchase $100.00 million in shares. This repurchase authorization authorizes the semiconductor company to repurchase up to 5.2% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's leadership believes its stock is undervalued.
Axcelis Technologies Profile
(
Free Report)
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.
Recommended Stories

Before you consider Axcelis Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axcelis Technologies wasn't on the list.
While Axcelis Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.